Napier Port Holdings (NZE:NPH) repurchased 97,774 ordinary shares for NZ$3.5992 per security on Monday under an on-market buyback program, according to a Tuesday filing with the New Zealand bourse.
Following the transaction, the company's ordinary shares consists of 199.8 million shares and 187,462 shares held in treasury, per the filing.
Eagers Automotive (ASX:APE) underperformed the ASX 300 index by 25% since Sept. 30, 2025, and is currently one of the few "appealing" ASX discretionary stocks, Jefferies said in a May 25 note, recommending that investors buy the dip.The investment firm views Eagers Automotive's recently completed acquisition of CanadaOne positively, saying that CanadaOne is outperforming the Canadian market.Additionally, with its easyauto123 used car retail brand, Eagers Automotive is expected to outperform system used vehicle volumes, Jefferies said.The company's upcoming annual general meeting on Wednesday will probably include some positives and negatives, but the positives should outweigh the negatives overall, Jefferies said. It added that Eagers Automotive will probably not provide any explicit guidance for fiscal 2026.The equity research firm expects Eagers Automotive to be "easily outperforming" the flat Australian market in the calendar 2026 year to date, with its acquisition of Grand Motors and Zagame taking its domestic share to 15% from June.Jefferies maintained a buy rating on the company with a price target of AU$30.50.Eagers Automotive's shares were up over 1% in recent Tuesday trade.
Industrial and Commercial Bank of China (SHA:601398) raised 60 billion yuan via the issue of 10-year bonds with a coupon rate of 1.90%.Proceeds will be used to replenish capital, according to a Monday filing with the Shanghai bourse.
MicroPort NeuroScientific's (HKG:2172) subsidiary, MicroPort NeuroTech (Shanghai), received U.S. Food and Drug Administration approval to market the Numen Helia Coil Embolization System, according to a Monday Hong Kong bourse filing.Shares of the medical device company fell nearly 1% in Tuesday morning trade.The device is designed to obstruct or occlude blood flow in vascular abnormalities of neurovascular vessels through endovascular procedures, the filing said.